CIBC Bancorp USA’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$692K Buy
17,054
+7,673
+82% +$373K ﹤0.01% 1221
2026
Q2
$492K Buy
9,381
+1,136
+14% +$44.4K ﹤0.01% 1316
2026
Q1
$292K Buy
+8,245
New +$256K ﹤0.01% 1436
2025
Q3
$519K Buy
+17,296
New +$488K ﹤0.01% 854

Other funds holding ALKS

CIBC Bancorp USA's ALKS Position: Q3 2026 in Review

CIBC Bancorp USA increased its Alkermes (ALKS) stake by 82% in Q3 2026, buying an estimated $373K and bringing the position to 17,054 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.

CIBC Bancorp USA first reported a position in ALKS in Q3 2025 and has held it in 4 quarters since. 411 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • CIBC Bancorp USA held 17,054 shares of Alkermes worth $692K as of Q3 2026.
  • CIBC Bancorp USA bought 7,673 Alkermes shares in Q3 2026, an estimated $373K.
  • Alkermes made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1221 holding.
  • CIBC Bancorp USA first reported a position in Alkermes in Q3 2025 and has held it in 4 quarters since.
  • 411 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.